商品编号


F6140



品牌


UBPBio



公司


Ubiquitin-Proteasome Biotechnologies, LLC



公司分类


Inhibitors



Size

5 mg

商品信息

Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.

Additional Information






Product Name:

Everolimus



Also Known As:

N/A



Catalog No.:

F6140



Size:

5 mg



CAS:

159351-69-6



Formula:

C
53
H
83
NO
14



Molecular Weight:

5958.22 Da



Form:

Lyophilized powder



Quality Assurance:

>98% by HPLC and NMR



Source:

Synthetic



Storage:

Elig
IBL
e for room temperature shipping. Store at 2-8°C upon receiving



PDF Data Sheet:

Download PDF datasheet



Image(s):

N/A



Shipping Method:

Room temperature shipping



References:

Eisen HJ,
et al
. (2003). N. Engl. J. Med. 349 (9): 847–58.




Details

Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.